Cellular senescence: Ex Vivo p53-dependent asymmetric cell kinetics

Journal of Biomedicine and Biotechnology

Volumn 2001, Issue 1, 2001, Pages 28-37

  Rambhatla, Lakshmi ^a,c   Bohn, Shirley A ^a   Stadler, Patrizia B ^a   Boyd, Jonathan T ^a   Coss, Ronald A ^b   Sherley, James L ^a,d  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c GERON CORPORATION   (United States)

^d Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CELL AGING; CELL ISOLATION; CELL KINETICS; EX VIVO STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VIVO STUDY; PROTEIN FUNCTION; SOMATIC CELL; STEM CELL;

EID: 34249724470     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/S1110724301000079     Document Type: Article

References (45)

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621.
2. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-636.
3. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res. 1991;196:33-39.
4. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol. 1995;15:4745-4753.
5. INK4, and telomerase in immortalisation of human cells. Oncogene. 1995;11:971-976.
6. CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 1997;277:831-834.
7. Xu H-J, Zhou Y, Ji W, Perng G-S, et al. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 1997;15:2589-2596.
8. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 1998;396:84-88.
9. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Gen. 1997;17:498-502.
10. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
11. Zhu J, Wang H, Bishop JM, Blackburn EH. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA. 1999;96:3723-3728.
12. Weinberg RA. Bumps on the road to immortality. Nature. 1997;396:23-24.
13. Counter CM, Hahn WC, Wei W, et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci USA. 1999;95:14723-14728.
14. Halvorsen TL, Leibowitz G, Levine F. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol. 1999;19:1864-1870.
15. Wynford-Thomas D. Telomeres, p53, and cellular senescence, Oncol Res. 1996;8:387-398.
16. Vaziri H,West MD, Allsopp RC, et al. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 1997;16:6018-6033.
17. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature. 1999;400:464-468.
18. Sherley JL, Stadler PB, Johnson DR. Expression of the wild-type p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics. Proc Natl Acad Sci USA. 1995;92:136-140.
19. Sherley JL, Stadler PB, Stadler JS. A quantitativemethod for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells. Cell Prolif. 1995;28:137-144.
20. Sherley JL. The p53 tumor suppressor gene as regulator of somatic stem cell renewal division. Cope. 1996;12:9-10.
21. Poldosky DK. Regulation of intestinal epithelial proliferation a few answers, many questions. Am J Physiol. 1993;264:G179-G186.
22. Loeffler M, Potten CS. Stem cells and cellular pedigrees - a conceptual introduction. In: Potten CS, ed. Stem Cells. San Diego, CA: Harcourt Brace & Co.;1997:1-28.
23. Cairns J. Mutation selection and the natural history of cancer. Nature. 1975;255:197-200.
24. Herrero-Jimenez P, Thilly G, Southam PJ, et al. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States. Mutation Res. 1998;400:553-578.
25. Sherley JL. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration. J Biol Chem. 1991;266:24815-24828.
26. Liu Y, Riley LB, Bohn SA, Boice JA, Stadler PB, Sherley JL. Comparison of BAX, WAF1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions. J Cellular Physiology. 1998;177:364-376.
27. Liu Y, Bohn SA, Sherley JL. Inosine-5′-monophosphate dehydrogenase is a rate-determining factor for p53-dependent growth regulation. Mol Biol Cell. 1998;9:15-28.
28. Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963;17:299-313.
29. Harvey M, Sands AT, Weiss RS, et al. In vitro growth characterization of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 1993;8:2457-2467.
30. Tsukada T, Tomooka Y, Takai S, et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 1993;8:3313-3322.
31. Potten CS, Grant HK. The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine. British J Cancer. 1998;78:993-1003.
32. Kulju KS, Lehman JM. Increased p53 protein associated with aging in human diploid fibroblasts. Exp Cell Res. 1995;217:336-345.
33. Atadja P, Wong H, Garkavtsev I, Veillette C, Raibowol K. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA. 1995;92:8348-8352.
34. Bond J, Haughton M, Blaydes J, Gire V, Wynford-Thomas D, Nd Whyllie F. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene. 1996;13:2097-2104.
35. Harvey DM, Levine AJ. p53 alteration is a commonevent in the spontaneous immortalization of primary balb/c murine embryo fibroblasts. Genes Dev. 1991;5:2375-2385.
36. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS. Spontaneous in vitro immortalization of breast epithelial cells froma patientwith Li-Fraumeni syndrome. Mol Cell Biol. 1995;15:425-432.
37. Bond JA, Wyllie FS, Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene. 1994;9:1885-1889.
38. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA. 1997;94:9648-9653.
39. Orgel LE. Aging of clones of mammalian cells. Nature. 1973;243:441-445.
40. Miller DA. Human gene therapy comes of age, Nature. 1992;357:455-460.
41. Wilson JM. Vehicles for gene therapy. Nature. 1993;365:691-692.
42. Brenner MK. Gene transfer to hematopoietic cells. New Engl J Med.
43. Ross G, Erickson R, Knorr D, et al. Gene therapy in the United States: A five-year status report, Hum Gene Ther. 1996;7:1781-1790.
44. kipl for restriction point control of the fibroblast cell cycle. Science. 1996;272:877-880.
45. Sherley JL, Riley LB. Cell lines and methods for screening growth regulatory compounds. U.S. Patent. 1998;741(5):646.